China Opens Regulatory Review of Novo Nordisk’s Oral Wegovy in Major Obesity Drug Race
Shanghai, August 29, 2026: China has taken an important regulatory step toward potentially allowing Novo Nordisk’s oral version of Wegovy...
Shanghai, August 29, 2026: China has taken an important regulatory step toward potentially allowing Novo Nordisk’s oral version of Wegovy...
August 15, 2026: The global corporate landscape is increasingly being shaped by artificial intelligence, semiconductors, cloud computing and advanced technology,...